International Cannabis Weekly: 334
January 26, 2024
Highlights
Share this story
Highlights
AUSTRALIA CITED AS WORLD’S FASTEST-GROWING MEDICAL CANNABIS MARKET
Global commentators herald Australia as the fastest-growing medical market in the world and expect stellar 2023 growth to be repeated in the next 12 months.
GERMAN HEALTH MINISTER EXPECTS ADULT-USE LEGALISATION BY APRIL
DETAILS OF NEW YORK’S HOME CULTIVATION REGULATIONS RELEASED BY THE CCB
Highlights
Share this story
Europe
- Czech Republic contemplates cannabis legalisation following the German model, according to recent developments.
- Deteriorating SPD support threatens Germany’s cannabis legalisation bill, recent reports suggest.
- Study finds medical cannabis could provide relief for patients with MS, diabetes or spinal injuries.
- Belgian Centre for Alcohol and Other Drugs (VAD) advocates decriminalisation of cannabis.
- First findings on cannabis and long COVID published by UK researchers in recent study.
- UK grant backs research on hemp fibres for integration into sustainable electronics manufacturing.
Highlights
Share this story
Stocks
Highlights
Share this story
United States
- More than US$1.3 billion worth of cannabis sales were recorded in Missouri in 2023, state figures say.
- Activists in Texas initiate signature drive for local cannabis decriminalisation ballot measures.
- Minnesota cannabis regulators suggest amendments to legislation for quicker licensing.
- New Jersey regulators give the green light to final rules for cannabis consumption lounges.
- Washington legislators review diverse cannabis bills on topics Like home cultivation and THC limits.
- Massachusetts boasts a historic year for cannabis sales with US$1.8 billion registered in ‘booming’ industry.
Highlights
Share this story
New Report
Highlights
Share this story
Canada
- British American Tobacco’s C$124 million investment in Organigram is approved by shareholders.
- Non-medical cannabis added to Canadian Free Trade Agreement (CFTA), but cross-province sales unlikely.
- Canopy Growth secures US$35 million through sale of units to ‘strengthen financial position’.
- Aurora reveals cannabis-infused, ready-to-drink beverage in latest medical product launch.
- British Columbia faces challenges and lacks significant progress in establishing a flourishing cannabis industry.
- Canadian cannabis licence approvals hit a multi-year low amid current market turbulence.
Highlights
Share this story
Webinar
Highlights
Share this story
LATAM & The Caribbean
- Uruguay’s cannabis legalisation initiative extends to tourists in further progressive policy reform.
- Brazil’s Superior Court of Justice (STJ) grants injunctions allowing patients to grow cannabis at home.
- Decree confirms that Argentina’s REPROCANN medical cannabis programme can continue.
- Paraguay celebrates first export of hemp flowers in landmark achievement for the countries hemp industry.
Highlights
Share this story
APAC
- Australian cannabis producer ECS Botanics achieves record sales, reporting AU$7 million in quarterly revenue.
- Recent poll finds 50% of Australian voters back home cultivation of adult-use cannabis.
- The medical use of cannabis may require a doctor’s note, Thai government minister confirms.
- Melodiol Global Health raises funds and considers the potential sale of ‘various core assets’.
Highlights
Share this story
Africa & The Middle East
- Tasmanian Botanics shifts growing operations to new 1.1 hectare greenhouse in strategic expansion.
- Australia and New Zealand revamp regulations to elevate global presence in the cannabis industry.
- Federation TAFE introduces course on cultivating medical cannabis to address industry demand.
- Althea claimed its softgels capsules are convincing more doctors to experiment with medicinal cannabis.
Insights
on the global cannabis industry
International Cannabis Weekly newsletter brings you the most important developments, news and informed commentary on the global cannabis industry. Join our community of 80,000+ subscribers.